Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold... see more

CSE:SONA - Post Discussion

Sona Nanotech Inc > SONA GNR technologie remains the best !!
View:
Post by wintrader on Oct 29, 2020 2:05pm

SONA GNR technologie remains the best !!

Market overeaction today from Trump political decision to bet on herd immunity is a nonsense ...
Sona market is worlwide and this is the proof that their technology work !!  FDA did not denied SONA GNR  technology at all ... in fact '' is not a priority ''  .  To me , look's like Trump is protecting big US Pharma in a certain way . America first !! 

On a positive note and read carefully  :  ''Health Canada continues its evaluation of the Company's application for an Interim Order ("IO") authorization for its test as a 'point-of-care' medical diagnostic device. The Company yesterday received additional questions on its application. Also, Health Canada has submitted the Company's tests to the Public Health Agency of Canada's National Microbiology Laboratory for evaluation, which is ongoing.''

Sona was third party evaluated and now is under another party evaluation ... This should give them the same amazing results they got from MRI Global and SaudiVax  ! I am totally confident about Sona results ! They will amaze them .

In addition to that , Sona keeps working on saliva test :  


The Sona lab has recently completed work on a the next evolution of its rapid COVID-19 antigen test which aims to use saliva samples, building on its existing technology, providing for less invasive sample collection. The saliva test would use the existing Sona lateral flow cassette. The Company expects to announce more details and clinical testing plans for the saliva test in the near future. This test would require a separate submission to regulators for approval to be used as a medical diagnostic device.

I have full trust in SONA disruptive technology despite Trump political interference in this process .... US is not the main market for SONA   !  But the rest of the world is ...

Bashers/shorters are having fun today ,  but mark my words , Sona will recovered 

GLTA !    Not selling a single share !! Holding strong again .
Comment by Hightide22 on Oct 29, 2020 2:32pm
Just to add to your post: Sona was third party evaluated and now is under another party evaluation ... This should give them the same amazing results they got from MRI Global and SaudiVax  ! I am totally confident about Sona results ! They will amaze them . This 3rd party evaluation now is going to be from Health Canada since they asked for it. If the results are same as what SONA already ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities